Search filters

List of works by Alexander M Lesokhin

A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma

scientific article published on 8 May 2017

A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma

scientific article

Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1.

scientific article published on 29 February 2016

Clinical Development of PD-1 Blockade in Hematologic Malignancies

scientific article published in January 2018

Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes

scientific article

Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs

scientific article

Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma

scientific article published on 30 May 2017

Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: experience at Memorial Sloan Kettering Cancer Center ⬇️

scientific article published on January 21, 2013

Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study

scientific article published on 01 March 2021

Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation

scientific article published on 12 January 2017

Harnessing the immune system for cancer therapy

scientific article

Hiding the road signs that lead to tumor immunity

scientific article

Immune checkpoint blockade for hematologic malignancies: a review

scientific article

Immunologic correlates of the abscopal effect in a patient with melanoma

scientific article (publication date: 8 March 2012)

Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance

scientific article published on 9 May 2017

Immunotherapy of Lymphoma and Myeloma: Facts and Hopes.

scientific article published on 12 September 2017

Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype

scientific article

Inhibition of chemokine expression by adenovirus early region three (E3) genes

scientific article

Lessons Learned from Checkpoint Blockade Targeting PD-1 in Multiple Myeloma

scientific article published on 01 August 2019

Long-term remissions after stopping pembrolizumab for relapsed or refractory multiple myeloma

scientific article published on 01 June 2019

Maintenance therapy and need for cessation studies in multiple myeloma: Focus on the future

scientific article published on 11 January 2020

Markers for anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) therapy in melanoma

Minimal residual disease in multiple myeloma: bringing the bench to the bedside

scientific article

Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition

scientific article published on 01 July 2019

Monoclonal antibodies in multiple myeloma: Current and emerging targets and mechanisms of action

scientific article published on 11 January 2020

Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment

scientific article published on 15 December 2011

Myeloid-derived suppressor sells and the efficacy of CD8(+) T-cell immunotherapy

scientific article published on February 2013

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

scientific article

Nivolumab plus ipilimumab in advanced melanoma

scientific article

OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis.

scientific article published on 04 May 2009

On being less tolerant: enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation

scientific article published on March 2015

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

scientific article (publication date: 22 January 2015)

Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients’ monitoring after transplantation ⬇️

scientific article published on August 13, 2012

Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma

scientific article

Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab.

scientific article published on 6 May 2014

Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab.

scientific article published on 7 November 2013

Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma

scientific article published on 28 March 2016

Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.

scientific article published on 19 September 2016

Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: incidence and prognostic significance ⬇️

scientific article published on April 23, 2013

Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity.

scientific article

Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance.

scientific article

Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.

scientific article published on 30 March 2009

Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies

scientific article published on 01 August 2019

Significant Nationwide Variability in the Costs and Hospital Mortality Rates of Autologous Stem Cell Transplantation for Multiple Myeloma: An Analysis of the Nationwide Inpatient Sample Database

scientific article published on 06 September 2018

Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity 1 with Novel Induction Regimens in Multiple Myeloma

scientific article published on 19 May 2020

T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy

scientific article published on 13 October 2015

Transjugular Liver Biopsy in a Multiple Myeloma Patient with Hepatomegaly, Portal Hypertension and "Miliary" Liver Lesions: A Case Report

scientific article published on 10 February 2016

Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood

scientific article published on 21 September 2016

Paulina is supported by:

About Paulina

Help